vs

Side-by-side financial comparison of Oncology Institute, Inc. (TOI) and VARONIS SYSTEMS INC (VRNS). Click either name above to swap in a different company.

VARONIS SYSTEMS INC is the larger business by last-quarter revenue ($173.1M vs $142.0M, roughly 1.2× Oncology Institute, Inc.). On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 26.9%). VARONIS SYSTEMS INC produced more free cash flow last quarter ($49.0M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 15.2%).

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

Varonis Systems, Inc. is a software company based in Miami, Florida with R&D offices in Herzliya, Israel. The company’s Data Security Platform analyzes data and data activity using the insights to identify data exposure risks stemming from access permissions and software-as-a-service (SaaS) app configurations, triggering automated remediation capabilities in response.

TOI vs VRNS — Head-to-Head

Bigger by revenue
VRNS
VRNS
1.2× larger
VRNS
$173.1M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+14.7% gap
TOI
41.6%
26.9%
VRNS
More free cash flow
VRNS
VRNS
$46.9M more FCF
VRNS
$49.0M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
15.2%
VRNS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
TOI
TOI
VRNS
VRNS
Revenue
$142.0M
$173.1M
Net Profit
$-7.5M
Gross Margin
76.0%
Operating Margin
-4.9%
Net Margin
-5.3%
Revenue YoY
41.6%
26.9%
Net Profit YoY
43.0%
EPS (diluted)
$-0.04
$115788061.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TOI
TOI
VRNS
VRNS
Q1 26
$173.1M
Q4 25
$142.0M
$173.4M
Q3 25
$136.6M
$161.6M
Q2 25
$119.8M
$152.2M
Q1 25
$104.4M
$136.4M
Q4 24
$100.3M
$158.5M
Q3 24
$99.9M
$148.1M
Q2 24
$98.6M
$130.3M
Net Profit
TOI
TOI
VRNS
VRNS
Q1 26
Q4 25
$-7.5M
$-27.8M
Q3 25
$-16.5M
$-29.9M
Q2 25
$-17.0M
$-35.8M
Q1 25
$-19.6M
$-35.8M
Q4 24
$-13.2M
$-13.0M
Q3 24
$-16.1M
$-18.3M
Q2 24
$-15.5M
$-23.9M
Gross Margin
TOI
TOI
VRNS
VRNS
Q1 26
76.0%
Q4 25
78.9%
Q3 25
78.2%
Q2 25
79.5%
Q1 25
78.7%
Q4 24
83.6%
Q3 24
83.8%
Q2 24
82.8%
Operating Margin
TOI
TOI
VRNS
VRNS
Q1 26
Q4 25
-4.9%
-17.5%
Q3 25
-5.9%
-22.2%
Q2 25
-9.4%
-24.0%
Q1 25
-9.5%
-32.1%
Q4 24
-11.9%
-11.1%
Q3 24
-13.9%
-16.0%
Q2 24
-16.6%
-22.1%
Net Margin
TOI
TOI
VRNS
VRNS
Q1 26
Q4 25
-5.3%
-16.0%
Q3 25
-12.1%
-18.5%
Q2 25
-14.2%
-23.5%
Q1 25
-18.8%
-26.2%
Q4 24
-13.1%
-8.2%
Q3 24
-16.1%
-12.4%
Q2 24
-15.7%
-18.4%
EPS (diluted)
TOI
TOI
VRNS
VRNS
Q1 26
$115788061.00
Q4 25
$-0.04
$-0.23
Q3 25
$-0.14
$-0.26
Q2 25
$-0.15
$-0.32
Q1 25
$-0.21
$-0.32
Q4 24
$-0.14
$-0.12
Q3 24
$-0.18
$-0.16
Q2 24
$-0.17
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TOI
TOI
VRNS
VRNS
Cash + ST InvestmentsLiquidity on hand
$179.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-15.7M
$453.5M
Total Assets
$164.7M
$1.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TOI
TOI
VRNS
VRNS
Q1 26
$179.3M
Q4 25
$883.7M
Q3 25
$671.3M
Q2 25
$770.9M
Q1 25
$567.6M
Q4 24
$529.0M
Q3 24
$844.8M
Q2 24
$9.9M
$582.5M
Stockholders' Equity
TOI
TOI
VRNS
VRNS
Q1 26
$453.5M
Q4 25
$-15.7M
$598.7M
Q3 25
$-12.3M
$604.8M
Q2 25
$-9.0M
$341.5M
Q1 25
$5.1M
$367.7M
Q4 24
$3.6M
$455.7M
Q3 24
$15.5M
$428.6M
Q2 24
$29.2M
$458.6M
Total Assets
TOI
TOI
VRNS
VRNS
Q1 26
$1.6B
Q4 25
$164.7M
$1.8B
Q3 25
$163.6M
$1.7B
Q2 25
$159.8M
$1.6B
Q1 25
$164.0M
$1.6B
Q4 24
$172.7M
$1.7B
Q3 24
$179.2M
$1.5B
Q2 24
$179.6M
$1.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TOI
TOI
VRNS
VRNS
Operating Cash FlowLast quarter
$3.2M
$55.0M
Free Cash FlowOCF − Capex
$2.2M
$49.0M
FCF MarginFCF / Revenue
1.5%
28.3%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M
$118.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TOI
TOI
VRNS
VRNS
Q1 26
$55.0M
Q4 25
$3.2M
$24.7M
Q3 25
$-12.6M
$33.4M
Q2 25
$-10.2M
$21.3M
Q1 25
$-5.0M
$68.0M
Q4 24
$4.2M
$24.3M
Q3 24
$819.0K
$22.5M
Q2 24
$-15.7M
$11.7M
Free Cash Flow
TOI
TOI
VRNS
VRNS
Q1 26
$49.0M
Q4 25
$2.2M
$20.7M
Q3 25
$-13.2M
$30.4M
Q2 25
$-11.4M
$18.0M
Q1 25
$-5.3M
$65.7M
Q4 24
$2.4M
$19.9M
Q3 24
$417.0K
$21.3M
Q2 24
$-17.5M
$10.9M
FCF Margin
TOI
TOI
VRNS
VRNS
Q1 26
28.3%
Q4 25
1.5%
12.0%
Q3 25
-9.7%
18.8%
Q2 25
-9.5%
11.8%
Q1 25
-5.1%
48.1%
Q4 24
2.4%
12.6%
Q3 24
0.4%
14.4%
Q2 24
-17.7%
8.4%
Capex Intensity
TOI
TOI
VRNS
VRNS
Q1 26
Q4 25
0.7%
2.3%
Q3 25
0.4%
1.8%
Q2 25
1.0%
2.2%
Q1 25
0.3%
1.7%
Q4 24
1.8%
2.7%
Q3 24
0.4%
0.8%
Q2 24
1.9%
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

VRNS
VRNS

SaaS$161.1M93%
Term license subscriptions$6.9M4%
Maintenance and services$5.2M3%

Related Comparisons